Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sirolimus in the Treatment for Propranolol-resistant Infantile Hepatic Hemangioendothelioma

NCT04406870 is registered in ClinicalTrials.gov with Shanghai Children's Medical Center as lead sponsor.

NCT NCT04406870
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04406870 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sirolimus in the Treatment for Propranolol-resistant Infantile Hepatic Hemangioendothelioma
Lead sponsor
Shanghai Children's Medical Center
Phase
Phase 4
Overall status
Unknown status
Start date
July 31, 2020
Completion date
June 30, 2025
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemangioendothelioma of liver